You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0444 Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFS and Correlated with Clinical Outcomes as Measured by DAS28(ESR)

Article info

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - other biologic treatment
AB0444 Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFS and Correlated with Clinical Outcomes as Measured by DAS28(ESR)

Authors

Citation

Gaylis N, Needell S, Sagliani J
AB0444 Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFS and Correlated with Clinical Outcomes as Measured by DAS28(ESR)
Annals of the Rheumatic Diseases 2014;73:955.

Publication history

  • First published June 10, 2014.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions